Real-World Outcomes of Descemet Membrane Endothelial Keratoplasty: 5 Years Single-Center Experience
DOI:
https://doi.org/10.48560/rspo.28057Keywords:
Corneal Transplantation, Descemet Stripping Endothelial Keratoplasty, Fuchs’ Endothelial DystrophyAbstract
INTRODUCTION: Our objective was to evaluate the 5-year clinical outcomes of a case series after Descemet membrane endothelial keratoplasty (DMEK) in a tertiary hospital center.
METHODS: Retrospective, single-center, observational cohort revision of the DMEK surgeries performed between August 2016 and August 2022.
Main outcome parameters (survival graft, best-corrected visual acuity (BCVA) in logMAR scale, and central endothelial cell density (ECD) were recorded. Intra, postoperative complica- tions, and the need for subsequent keratoplasties were considered secondary outcomes.
RESULTS: A total of 69 DMEKs, in 56 patients, were performed in our center between Au- gust 2016 and August 2022. The mean age of the patients at surgery was 65.91 ± 11.82 years. A percentage of 62.5% were female while 37.5% male. The leading indication for surgery was Fuchs dystrophy, followed by pseudophakic bullous keratopathy, corneal decompensation from previ- ous keratoplasties, and bullous keratopathy associated with phakic lens. Mean BCVA improved from 0.75 ± 0.26 (LogMAR) to 0.24 ± 0.23 at 1 year follow-up (N=57, p<0.001)). At 5 years-follow-up (N= 9), mean BCVA was 0.44 ± 0.24 (range 0.1 – 0.7) and mean ECD was 854.75 ± 218.97 cells/mm2. After the first year, an annual rate of ECD loss was calculated to be 12.9% (range, 8.7% to 16.1%).
Six eyes needed rebubbling. Allograft rejection was diagnosed in only one eye. Overall graft survival was 95.5 ± 2.5% at six months, 94.0 ± 2.9% at 1 year, 88.3 ± 4.2% at 2 years and 75.7 ± 7.9% at 5 years. Ten eyes underwent retransplantation.
CONCLUSION: Most eyes that underwent DMEK showed stable clinical outcomes with an early significant improvement in visual acuity. The overall results suggest that DMEK is a safe and effective treatment option for corneal endothelial diseases.
Downloads
References
Moshirfar M, Thomson AC, Ronquillo Y. Corneal Endothelial Transplantation. In: StatPearls. Treasure Island (FL): StatPearls Publishing
Copyright © 2022, StatPearls Publishing LLC.; 2022.
Singh NP, Said DG, Dua HS. Lamellar keratoplasty techniques. Indian J Ophthalmol. 2018;66(9):1239-1250.
Marques RE, Guerra PS, Sousa DC, Gonçalves AI, Quintas AM, Rodrigues W. DMEK versus DSAEK for Fuchs' endothelial dystrophy: A meta-analysis. Eur J Ophthalmol. 2019;29(1):15-22.
Melles GR, Ong TS, Ververs B, van der Wees J. Descemet membrane endothelial keratoplasty (DMEK). Cornea. 2006;25(8):987-990.
Dunker SL, Veldman MHJ, Winkens B, et al. Real-World Outcomes of DMEK: A Prospective Dutch registry study. Am J Ophthalmol. 2021;222:218-225.
Torres-Costa S, Pinheiro-Costa J, Torrão L, Moreira R, Falcão-Reis F. Descemet Membrane Endothelial Keratoplasty (DMEK) dois anos de experiência no Centro Hospitalar Universitário de São João. Oftalmologia. 2020;44.
Dapena I, Moutsouris K, Droutsas K, Ham L, van Dijk K, Melles GR. Standardized "no-touch" technique for descemet membrane endothelial keratoplasty. Arch Ophthalmol. 2011;129(1):88-94.
Stuart AJ, Romano V, Virgili G, Shortt AJ. Descemet's membrane endothelial keratoplasty (DMEK) versus Descemet's stripping automated endothelial keratoplasty (DSAEK) for corneal endothelial failure. Cochrane Database Syst Rev. 2018;6(6):Cd012097.
Oellerich S, Baydoun L, Peraza-Nieves J, et al. Multicenter Study of 6-Month Clinical Outcomes After Descemet Membrane Endothelial Keratoplasty. Cornea. 2017;36(12):1467-1476.
Rodríguez-Calvo-de-Mora M, Quilendrino R, Ham L, et al. Clinical outcome of 500 consecutive cases undergoing Descemet's membrane endothelial keratoplasty. Ophthalmology. 2015;122(3):464-470.
Schlögl A, Tourtas T, Kruse FE, Weller JM. Long-term Clinical Outcome After Descemet Membrane Endothelial Keratoplasty. American Journal of Ophthalmology. 2016;169:218-226.
Monnereau C, Quilendrino R, Dapena I, et al. Multicenter study of descemet membrane endothelial keratoplasty: first case series of 18 surgeons. JAMA Ophthalmol. 2014;132(10):1192-1198.
Birbal RS, Ni Dhubhghaill S, Bourgonje VJA, et al. Five-Year Graft Survival and Clinical Outcomes of 500 Consecutive Cases After Descemet Membrane Endothelial Keratoplasty. Cornea. 2020;39(3):290-297.
Ham L, Dapena I, Liarakos VS, et al. Midterm Results of Descemet Membrane Endothelial Keratoplasty: 4 to 7 Years Clinical Outcome. American Journal of Ophthalmology. 2016;171:113-121.
Vasiliauskaitė I, Oellerich S, Ham L, et al. Descemet Membrane Endothelial Keratoplasty: Ten-Year Graft Survival and Clinical Outcomes. Am J Ophthalmol. 2020;217:114-120.
Quilendrino R, Rodriguez-Calvo de Mora M, Baydoun L, et al. Prevention and Management of Descemet Membrane Endothelial Keratoplasty Complications. Cornea. 2017;36(9):1089-1095.
Chamberlain W, Lin CC, Austin A, et al. Descemet Endothelial Thickness Comparison Trial: A Randomized Trial Comparing Ultrathin Descemet Stripping Automated Endothelial Keratoplasty with Descemet Membrane Endothelial Keratoplasty. Ophthalmology. 2019;126(1):19-26.
Dunker SL, Dickman MM, Wisse RPL, et al. Descemet Membrane Endothelial Keratoplasty versus Ultrathin Descemet Stripping Automated Endothelial Keratoplasty: A Multicenter Randomized Controlled Clinical Trial. Ophthalmology. 2020;127(9):1152-1159.
Gorovoy MS. DMEK Complications. Cornea. 2014;33(1):101-104.
Hos D, Tuac O, Schaub F, et al. Incidence and Clinical Course of Immune Reactions after Descemet Membrane Endothelial Keratoplasty: Retrospective Analysis of 1000 Consecutive Eyes. Ophthalmology. 2017;124(4):512-518.
Price MO, Scanameo A, Feng MT, Price FW, Jr. Descemet's Membrane Endothelial Keratoplasty: Risk of Immunologic Rejection Episodes after Discontinuing Topical Corticosteroids. Ophthalmology. 2016;123(6):1232-1236.
Ćirković A, Schlötzer-Schrehardt U, Weller JM, Kruse FE, Tourtas T. Clinical and ultrastructural characteristics of graft failure in DMEK: 1-year results after repeat DMEK. Cornea. 2015;34(1):11-17.
Ham L, Dapena I, van der Wees J, Melles GR. Secondary DMEK for poor visual outcome after DSEK: donor posterior stroma may limit visual acuity in endothelial keratoplasty. Cornea. 2010;29(11):1278-1283.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Revista Sociedade Portuguesa de Oftalmologia
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Do not forget to download the Authorship responsibility statement/Authorization for Publication and Conflict of Interest.
The article can only be submitted with these two documents.
To obtain the Authorship responsibility statement/Authorization for Publication file, click here.
To obtain the Conflict of Interest file (ICMJE template), click here
